KYBORA’s mission is to

Guide Transformative Healthcare Companies to Enduring Success Globally

Our name comes from the word "kuyobora" which means guide in Kinyarwanda, the language of our founder’s country of birth.

Our purpose is to help clients make and implement optimal corporate and business development decisions throughout the lifetime of their businesses.

We are driven to create long-term value for our clients, who rely on our experience, relationships, knowledge of the industry and global direct presence to provide them with a proven path to success.

We help life sciences companies of all sizes develop and grow all over the world.

We are
Kybora.

Our Story

KYBORA was created to help companies do deals in complex markets. It is now a global advisory firm that generates value to clients worldwide.

Our Services

Our services include fundraising, licensing, search and evaluation, mergers & acquisitions, divestitures and strategic consulting.

Our Experience

KYBORA is a global value creator for biopharma companies. We offer the best combination of global reach and local knowledge.

We operate in

All major biopharma markets around the world
Our track record of successes all over the world is unparalleled in the industry.
KYBORA is a global value creator for biopharma companies. We offer the best combination of global reach and local knowledge.

Our Services.

Our mission is to help our clients achieve enduring success in a complex global environment. We do this by helping companies make the right strategic decisions, grow through acquisitions, license their products, find innovation, raise funds, and/or sell themselves in a way that maximizes value for their shareholders. The services we offer include:

Mergers & Acquisitions Services

Licensing Services

Fundraising Services

Strategic Advisory Services

Testimonials

What our Clients say.

We gave the mandate to KYBORA to support Biocodex in the search for a commercial partner in China and they did a smart and extensive screening of the potential pharmaceutical companies fitting with Biocodex culture.
KYBORA’s support was really positive and helpful for Biocodex. This successful collaboration permits a quicker territory expansion and brings a lot of value added for Biocodex.

Hubert Chapellier.
Head of International Operations / Partnership at Biocodex
Hubert Chapellier

This partnership with Intas marks a signficant milestone for Xbrane as we work to expand global access to high-quality biosimilars. With Intas’s proven expertise in oncology and biosimilars, our nivolumab candidate is well-positioned to reach patients worldwide, providing a more affordable treatment option for cancer care.
We are grateful for KYBORA’s strategic guidance, which was instrumental in securing this transformative agreement and advancing our mission to make innovative therapies more accessibke globally.

Martin Åmark.
Chief Executive Officer at Xbrane
Martin Amark

I hired KYBORA for a tough sell-side assignment. They leveraged their deep network of relationships to find buyers that my team and I were thinking of, but quite a few more that we did not. KYBORA’s close relationships with numerous companies, particularly smaller caps and private biotechs really sets them apart. And most importantly, they got us results. We ended up with a closed deal. Not just interesting leads.

Thomas Gillespie.
Vice President, Global Business Development at Lupin
Thomas-Lupin

Cristália has worked with KYBORA in several initiatives, from strategic partnerships to M&A across Latin America.
The team is always reliable and highly professional when evaluating each opportunity. The broad experience in their respective markets is also translated into solutions, helping their clients to find alternative approaches to maximize each business opportunity. For their experience, regional knowledge and trust I recommend KYBORA as the best partner in Pharma M&A business.

Julio Cordeiro.
Director M&A at Cristália

Cellaïon is delighted to partner with KYBORA for its fundraising and financial operations activities.
KYBORA’ long standing experience in biotech financement and M1A is highly appreciated and respected by all stakeholders in the biotech community. Our relation is based on trust and long term view of a win win partnership.

Etienne Sokal.
MD, PhD CEO of Cellaion

A genuinely excellent advisory firm. KYBORA’s seasoned professionals, through their extensive relationships with industry leaders worldwide and deep market insights, are uniquely suited to help business development teams identify and execute licensing deals.

Laurence Mallick.
Director New Business Development J&J

KYBORA has been a fantastic business development partner for Maypro. They’ve brought us some really exciting licensing opportunities from Latin America and the Middle East, which have opened new doors for us with a lot of upside. We’ve also worked on some M&A opportunities and they are our go-to partner on corporate developments projects in the emerging markets.

Dan Lifton.
President, Maypro Ventures

We have been working with KYBORA during last years in several pharma projects across Latin America. Great team joined by highly qualified and experienced professional experts in their respective markets. For their commitment, creativity and permanent support KYBORA is the perfect partner for the M&A business in Pharma.

Enrique Odriozola.
Head of M&A at Megalabs
Testimonials Enrique Odriozola

Our Global Presence.

KYBORA offers the best combination of global presence and local knowledge. KYBORA is headquartered in Princeton, NJ and has offices in Basel, Switzerland, and Shanghai, China. KYBORA operates directly in all key biopharma markets around the world.

Our Leadership.
Alan
Chief Executive Officer
Partner, Executive Vice President, and Managing Director Europe
Stephen Stead, Kybora
Board Member and Advisor
Partner and Managing Director

TYPE & ENTER: